Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches

Area of Science:

• Oncology
• Metabolomics
• Bioinformatics

Background:

• Prostate cancer (PCa) is a heterogeneous malignancy in men.
• PCa cells exhibit metabolic reprogramming to support their growth and survival.
• Understanding metabolic changes is crucial for PCa diagnosis, prognosis, and treatment.

Purpose of the Study:

• To review multi-omics studies characterizing the metabolomic phenotype of PCa.
• To analyze the correlation between multi-omics findings and PCa metabolic profiles.
• To highlight the potential of integrated omics for PCa research and clinical application.

Main Methods:

• Review of recent literature on multi-omics data integration in PCa.
• Analysis of genomics, epigenomics, transcriptomics, proteomics, lipidomics, and metabolomics studies.
• Correlation analysis between molecular changes and tumor metabolic profiles.

Main Results:

• Multi-omics integration reveals specific metabolic reprogramming events in PCa.
• Identified metabolic vulnerabilities offer potential therapeutic targets.
• Integrated data provides deeper insights into PCa heterogeneity and progression.

Conclusions:

• Multi-omics approaches are powerful tools for understanding PCa metabolic rewiring.
• Characterizing the PCa metabolomic phenotype can guide personalized therapy.
• Further research integrating multi-omics data may improve patient outcomes.